Table II.
Treatment details.
| Characteristic | Number (%) (n=161) |
|---|---|
| Surgery (anterior resection of rectum vs. abdominoperineal resection) | 74/161 (45.96) |
| Resection margin (R0 vs. R1) | 138/161 (85.71) |
| Type of first adjuvant treatment (CRT vs. CT) | 84/161 (52.17) |
| Time until first adjuvant treatment ≤28 days | 34/161 (21.12) |
| Time between surgery and RT ≤42 days | 21/161 (13.04) |
| Adjuvant therapy (C RT 45Gy vs. CRT 50Gy) | 119/161 (73.91) |
|
| |
| Chemotherapy type | 5-FU/LV: 99/143 (69.23) CAPECITABINE: 37/143 (25.87) FOLFOX: 4/143 (2.8) XELOX: 3/143 (2.1) |
|
| |
| Chemotherapy line | 1: 132/161 (81.99) 2: 12/161 (7.45) 3: 14/161 (8.7) 4: 1/161 (0.62) 5: 2/161 (1.24) |
CRT: chemoradiotherapy; RT: radiotherapy; 5-FU/LV: 5-fluorouracil with leucovorin